Found 6 matching trials
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients PHASE3 The purpose of this study is to evaluate the safety and tolerability of Ora...
Show More Location
Cullman Oncology and Hematology
Learn More & Join Trial
OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients PHASE3 The purpose of this study is to evaluate the long-term safety and efficacy ...
Show More Location
Center for Pain Management
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain PHASE3 A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effica...
Show More Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain PHASE3 The purpose of the study is to evaluate the efficacy and safety of OraVesce...
Show More Location
Hot Springs Pain Clinic
Learn More & Join Trial
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain PHASE3 The purpose of this study is to evaluate the safety and tolerability of Ora...
Show More Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain PHASE3 A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effica...
Show More Learn More & Join Trial